Integrated analysis for treatment scheme of sodium–glucose cotransporter 2 inhibitors in patients with diabetic kidney disease: a real-world study

Sodium–glucose cotransporter 2 inhibitors (SGLT2i) are recommended for type 2 diabetes mellitus patients with impaired renal function, but the actual situation of SGLT2i using is unclear. Therefore, in this real-world study, we analyzed the treatment scheme and clinical characteristics of SGLT2i in...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Li, Li, Guangpu, Ren, Jingjing, Duan, Jiayu, Dong, Jiancheng, Liu, Zhangsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097684/
https://www.ncbi.nlm.nih.gov/pubmed/37045938
http://dx.doi.org/10.1038/s41598-023-33211-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097684/
https://www.ncbi.nlm.nih.gov/pubmed/37045938
http://dx.doi.org/10.1038/s41598-023-33211-1

Ejemplares similares